Clinical trial NCT00457093 - References

Type 2 Diabetes — A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

Citation(s)

•   Bode BW, Gross TM, Thornton KR, Mastrototaro JJ
  Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract. 1999 Dec;46(3):183-90. Erratum in: Diabetes Res Clin Pract 2000 Mar;47(3):225.
•   Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV
  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1858-62.
•   Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ
  Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2000 Spring;2(1):49-56.
•   Gross TM, Mastrototaro JJ
  Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 Suppl 1:S19-26.
•   Heise, T et al
  Diabetes 2003;52(Suppl.1):A121
•   King AB, Armstrong D
  A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine. Diabetes Care. 2003 Apr;26(4):1322.
•   King, AB, Armstrong, DU
  Presentation at Diabetes Technology & Therapeutics Meeting, 2003, San Francisco
•   Mastrototaro J
  The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab. 1999;12 Suppl 3:751-8. Review.
•   Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I
  Reproducibility of glucose measurements using the glucose sensor. Diabetes Care. 2002 Jul;25(7):1185-91.
•   Russell-Jones, D
  et al. Diabetologia 2002;45(Suppl. 2):A51

A Double Blind, Randomized, Parallel, Cross-Over Comparision of Glycemic Control Achieved With Once a Day Insulin Glargine Versus Detemir in Type 2 Diabetes

Details for clinical trial NCT00457093